Annual SG&A
$11.98B$11.72B+4,633.86%
Summary
- Current Value
- As of today, GSK annual SG&A is $11.98B, up +4633.86% on
- Historical Performance
- GSK annual SG&A is up +4964.23% over the past 3 years, and up +2189.18% over the past 5 years
- All-Time High Comparison
- GSK annual SG&A is currently -40.55% below its historical high of $20.15B set on
- 3-Year Low Comparison
- GSK annual SG&A is +4964.23% above its 3-year low of $236.50M reached on an earlier date
- Sector Comparison
- GSK annual SG&A is higher than 99.92% of companies in Healthcare sector
SG&A Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual SG&A | $11.98B | +4633.9% | +4964.2% | +2189.2% | -40.5% | |
| Quarterly SG&A | $3.51B | +2.8% | +22.7% | -15.9% | -50.0% | |
| TTM SG&A | $49.99B | +254.3% | +385.5% | +239.8% | +148.6% | |
| Price | $58.50 | +60.4% | +63.2% | +61.4% | +50.5% | |
| Annual Operating Expenses | $21.78B | +5.0% | +38.4% | +13.7% | -10.1% | |
| Annual Operating Profit | $9.45B | +30.6% | +14.8% | -10.0% | +22.9% | |
| Annual D&A | $4.98B | +52.7% | +88.3% | +65.2% | +92.1% | |
| Annual Revenue | $43.05B | +7.4% | +19.2% | -1.5% | -1.8% |
SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $11.98B | at high | |
| 5Y | $11.98B | at high | |
| All | $20.15B | -40.5% |
SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $236.50M | N/A | +4964.2% |
| 5Y | $232.43M | +5053.0% | |
| All | $0.00 | N/A |
SG&A History
FAQ
What is the current annual SG&A of GSK?
As of today, GSK annual SG&A is $11.98B
What is 1-year change in GSK annual SG&A?
GSK annual SG&A is up +4633.86% year-over-year
What is 3-year change in GSK annual SG&A?
GSK annual SG&A is up +4964.23% over the past 3 years
How far is GSK annual SG&A from its all-time high?
GSK annual SG&A is currently -40.55% below its historical high of $20.15B set on December 31, 2010
How does GSK annual SG&A rank versus sector peers?
GSK annual SG&A is higher than 99.92% of companies in Healthcare sector
When is GSK next annual earnings release?
As of today, the next annual earnings release for GSK has not been scheduled
Quarterly SG&A
$3.51B$489.98M+16.23%
Summary
- Current Value
- As of today, GSK quarterly SG&A is $3.51B, up +16.23% on
- Historical Performance
- GSK quarterly SG&A is up +2.83% year-over-year, and up +22.73% over the past 3 years
- All-Time High Comparison
- GSK quarterly SG&A is currently -50.02% below its historical high of $7.02B set on
- 3-Year Low Comparison
- GSK quarterly SG&A is +34.78% above its 3-year low of $2.60B reached on
- Sector Comparison
- GSK quarterly SG&A is higher than 99.73% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly SG&A | $3.51B | +16.2% | +2.8% | +22.7% | -15.9% | |
| Annual SG&A | $11.98B | – | +4633.9% | +4964.2% | +2189.2% | |
| TTM SG&A | $49.99B | +320.2% | +254.3% | +385.5% | +239.8% | |
| Price | $58.50 | +23.5% | +60.4% | +63.2% | +61.4% | |
| Quarterly Operating Expenses | $6.67B | +32.3% | +16.6% | +34.9% | +17.1% | |
| Quarterly Operating Profit | $1.28B | -63.0% | -10.3% | +13.2% | -33.3% | |
| Quarterly D&A | $1.39B | +32.4% | +21.9% | +1960.3% | -59.5% | |
| Quarterly Revenue | $11.46B | -0.6% | +10.2% | +32.5% | -0.7% |
Quarterly SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $3.51B | at high | |
| 3Y | $4.94B | -29.0% | |
| 5Y | $4.94B | -29.0% | |
| All | $7.02B | -50.0% |
Quarterly SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $2.61B | +34.6% | |
| 3Y | $2.60B | +34.8% | |
| 5Y | $2.31B | +51.7% | |
| All | $0.00 | N/A |
Quarterly SG&A History
FAQ
What is the current quarterly SG&A of GSK?
As of today, GSK quarterly SG&A is $3.51B
What is GSK quarterly SG&A most recent change?
GSK quarterly SG&A was up +16.23% on December 31, 2025
What is 1-year change in GSK quarterly SG&A?
GSK quarterly SG&A is up +2.83% year-over-year
How far is GSK quarterly SG&A from its all-time high?
GSK quarterly SG&A is currently -50.02% below its historical high of $7.02B set on December 31, 2010
How does GSK quarterly SG&A rank versus sector peers?
GSK quarterly SG&A is higher than 99.73% of companies in Healthcare sector
When is GSK next earnings release?
The next earnings release for GSK is on
TTM SG&A
$49.99B$3.97B+8.62%
Summary
- Current Value
- As of today, GSK TTM SG&A is $49.99B, up +8.62% on
- Historical Performance
- GSK TTM SG&A is up +254.33% year-over-year, and up +385.46% over the past 3 years
- All-Time High Comparison
- GSK TTM SG&A is currently -17.22% below its historical high of $60.39B set on an earlier date
- 3-Year Low Comparison
- GSK TTM SG&A is +95.92% above its 3-year low of $25.52B reached on an earlier date
- Sector Comparison
- GSK TTM SG&A is higher than 98.44% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM SG&A | $49.99B | +320.2% | +254.3% | +385.5% | +239.8% | |
| Annual SG&A | $11.98B | – | +4633.9% | +4964.2% | +2189.2% | |
| Quarterly SG&A | $3.51B | +16.2% | +2.8% | +22.7% | -15.9% | |
| Price | $58.50 | +23.5% | +60.4% | +63.2% | +61.4% | |
| TTM Operating Profit | $9.73B | -1.5% | +37.7% | +25.7% | +2.8% | |
| TTM D&A | $5.00B | +5.3% | +29.8% | +78.1% | +65.9% | |
| TTM Revenue | $43.11B | +2.5% | +7.5% | +19.1% | -1.5% |
TTM SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $49.99B | N/A | at high |
| 3Y | $49.99B | N/A | at high |
| 5Y | $49.99B | N/A | at high |
| All | $60.39B | N/A | -17.2% |
TTM SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $41.62B | N/A | +20.1% |
| 3Y | $25.52B | N/A | +95.9% |
| 5Y | $25.52B | N/A | +95.9% |
| All | -$29.95B | N/A | +266.9% |
TTM SG&A History
FAQ
What is the current TTM SG&A of GSK?
As of today, GSK TTM SG&A is $49.99B
What is GSK TTM SG&A most recent change?
GSK TTM SG&A was up +8.62% on December 31, 2025
What is 1-year change in GSK TTM SG&A?
GSK TTM SG&A is up +254.33% year-over-year
How does GSK TTM SG&A rank versus sector peers?
GSK TTM SG&A is higher than 98.44% of companies in Healthcare sector
When is GSK next earnings release?
The next earnings release for GSK is on
Selling, General & Administrative Expenses Formula
SG&A = Operating Expenses − Cost Of Goods Sold − R&D
Data Sources & References
- GSK Official Website www.gsk.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1131399/000165495426000892/0001654954-26-000892-index.htm
- GSK Profile on Yahoo Finance finance.yahoo.com/quote/GSK
- GSK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gsk